Syncom Healthcare Ltd.
BSE: 533157 | Sector: Health care |
NSE: SYNCOM | ISIN Code: INE602K01014 |
BSE 00:00 | 26 Feb | 2.47 |
-0.12 (-4.63%) |
OPEN
2.64 |
HIGH
2.64 |
LOW
2.47 |
NSE 00:00 | 26 Feb | 2.40 |
-0.10 (-4.00%) |
OPEN
2.60 |
HIGH
2.60 |
LOW
2.40 |
OPEN | 2.64 |
PREVIOUS CLOSE | 2.59 |
VOLUME | 67761 |
52-Week high | 4.18 |
52-Week low | 0.65 |
P/E | |
Mkt Cap.(Rs cr) | 10 |
Buy Price | 2.47 |
Buy Qty | 4473.00 |
Sell Price | 2.47 |
Sell Qty | 630.00 |
Syncom Healthcare Ltd. (SYNCOM) - Company Information
Syncom Healthcare Ltd is engaged in the manufacture marketing and trade of pharmaceutical formulations. The company manufactures a range of products such as Ethical drugs Generic drugs over the counter drugs (OTC) and Herbal formulations in various dosage forms and markets them under the trade mark Syncom.The company also undertakes contract manufacturing for large variety of pharmaceutical formul...> More
COMPANY INFORMATION | |||||||
Independent Director : | Sunita Garg | ||||||
Independent Director : | Tushar Patodia | ||||||
Managing Director : | Ajay Shankarlal Bankda | ||||||
Director : | Manoj Negi | ||||||
Independent Director : | Bhishampal Singh Yadav | ||||||
AUDITOR : | S G Kabra & Co | ||||||
IND NAME : | Pharmaceuticals - Indian - Formulations | ||||||
HOUSE NAME : | Indian Private | ||||||
Registered office | |||||||
502 Advent Atria, Chincholi Bunder Road Malad(W),Mumbai,Maharashtra-400064 | |||||||
Ph : 91-022-28813796/97 | |||||||
WEBSITE : http://www.syncomhealthcare.com | |||||||
E-mail : complianceofficer@syncom.in |
Quick Links for Syncom Healthcare:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices